Left Brain Wealth Management’s AbbVie ABBV Stock Holding History

Left Brain Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$587K	Sell	2,699 -40	-1%	-$8.87K	0.23%	52
2025 Q4	$626K	Hold	2,739	–	–	0.22%	53
2025 Q3	$634K	Sell	2,739 -1,006	-27%	-$205K	0.2%	61
2025 Q2	$695K	Sell	3,745 -225	-6%	-$41.8K	0.24%	54
2025 Q1	$832K	Sell	3,970 -325	-8%	-$63.2K	0.36%	46
2024 Q4	$763K	Sell	4,295 -425	-9%	-$78.1K	0.29%	51
2024 Q3	$932K	Sell	4,720 -694	-13%	-$130K	0.43%	45
2024 Q2	$929K	Sell	5,414 -40	-0.7%	-$6.63K	0.43%	41
2024 Q1	$993K	Sell	5,454 -412	-7%	-$71K	0.48%	41
2023 Q4	$909K	Sell	5,866 -132	-2%	-$19.2K	0.53%	45
2023 Q3	$894K	Sell	5,998 -1	-0%	-$147	0.56%	43
2023 Q2	$808K	Sell	5,999 -492	-8%	-$72.1K	0.49%	51
2023 Q1	$981K	Sell	6,491 -8,703	-57%	-$1.33M	0.67%	44
2022 Q4	$2.46M	Buy	+15,194	New	+$2.33M	1.84%	22

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Left Brain Wealth Management's ABBV Position: Q1 2026 in Review

Left Brain Wealth Management reduced its AbbVie (ABBV) stake by 1.5% in Q1 2026, selling an estimated $8.87K and leaving 2,699 shares worth $587K. The position accounts for 0.23% of the portfolio, ranked #52.

Left Brain Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.46M in Q4 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Left Brain Wealth Management held 2,699 shares of AbbVie worth $587K as of Q1 2026.
Left Brain Wealth Management sold 40 AbbVie shares in Q1 2026, an estimated $8.87K.
AbbVie made up 0.23% of Left Brain Wealth Management's portfolio in Q1 2026, its #52 holding.
Left Brain Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Left Brain Wealth Management's AbbVie position peaked at $2.46M in Q4 2022.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Left Brain Wealth Management's 13F filing for Q1 2026, filed 30 Apr 2026.